Abstract
Purpose
To study for the first time the incidence of adult-onset CNS tumors in Southern Sardinia, Italy.
Methods
Clinical records of patients > 18 years old who were diagnosed with primary CNS tumors during 2016–2019 in the study area were reviewed. Meningiomas, cranial/paraspinal nerve tumors, lymphomas, and pituitary tumors were excluded. Cases were classified according to the 2016 WHO classification of CNS tumors and to the morphology codes from the International Classification of Diseases—Oncology, third edition. Age-adjusted incidence rates were calculated by the direct method to the 2011–2020 European standard population. Kulldorff’s spatial scan statistic was used to identify geographic clusters of patients who shared increased/decreased tendency to develop CNS tumors.
Results
CNS tumors were diagnosed in 234 incident patients, but histological diagnosis was available in 222/234 patients (95%) aged 64.3 ± 13.5 years at diagnosis. Crude incidence rate was 7.1 per 100,000 persons-year (95% CI, 6.2–8.1), 6.2 per 100,000 persons-year (95% CI, 5.4–7.0) when age-adjusted. CNS tumors were more frequent in men and after age 40. Glioblastoma accounted for 76% of the total (adjusted rate, 4.7 per 100,000 persons-year; 95% CI, 4.0–5.4). Spatial analysis revealed geographic variations of glioblastoma incidence within the study area.
Conclusion
Although the distribution of tumor diagnoses in Sardinia reflects expected age and gender-related patterns in western populations, our findings would indicate a slightly higher incidence of glial tumors, glioblastoma in particular, in Sardinia than in other European countries. The identification of spatial clusters of high/low risk will serve as a resource for etiological research.
Similar content being viewed by others
References
Feigin VL, Nichols E, Alam T, Bannick MS, Beghi E, Blake N et al (2019) Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18:459–480. https://doi.org/10.1016/S1474-4422(18)30499-X
Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW, The, (2016) World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 131(2016):803–820. https://doi.org/10.1007/s00401-016-1545-1
World Health Organization (n.d.) International Classification of Diseases for Oncology, 3rd Edition (ICD-O-3)
Muroni A, Murru MR, Sechi M, Ercoli T, Marrosu F, Bentivoglio AR, Petracca M, Maria Scaglione CL, Soliveri P, Cocco E, Pedron M, Murgia M, Deriu M, Cuccu S, Ulgheri L, Zuccato C, Defazio G (2020) Prevalence of Huntington’s disease in Southern Sardinia, Italy, Park. Relat Disord 80:54–57. https://doi.org/10.1016/j.parkreldis.2020.09.011
Wesseling P, Capper D, WHO (2016) Classification of gliomas. Neuropathol Appl Neurobiol 44(2018):139–150. https://doi.org/10.1111/nan.12432
Kulldorff M (1997) A spatial scan statistic. Commun Stat Theory Meth 26:1848–1848. https://doi.org/10.1007/978-3-319-17885-1_101147
SaTScan (n.d.) Software for the spatial, temporal, and space-time scan statistics - https://www.satscan.org/
Ercoli T, Defazio G, Muroni A (2019) Cerebellar syndrome associated with thyroid disorders. Cerebellum 18:932–940. https://doi.org/10.1007/s12311-019-01059-9
Solla P, Masala C, Pinna I, Ercoli T, Loy F, Orofino G, Fadda L, Defazio G (2021) Frequency and determinants of olfactory hallucinations in Parkinson’s disease patients. Brain Sci 11:841. https://doi.org/10.3390/brainsci11070841
Sahai H, Khurshid A (1996) Formulae and tables for the determination of sample sizes and power in clinical trials for testing differences in proportions for the two-sample design: a review. Stat Med 15:1–21. https://doi.org/10.1002/(SICI)1097-0258(19960115)15:1%3c1::AID-SIM134%3e3.0.CO;2-E
Darlix A, Zouaoui S, Rigau V, Bessaoud F, Figarella-Branger D, Mathieu-Daudé H, Trétarre B, Bauchet F, Duffau H, Taillandier L, Bauchet L (2017) Epidemiology for primary brain tumors: a nationwide population-based study. J Neurooncol 131:525–546. https://doi.org/10.1007/s11060-016-2318-3
Wöhrer A, Waldhör T, Heinzl H, Hackl M, Feichtinger J, Gruber-Mösenbacher U, Kiefer A, Maier H, Motz R, Reiner-Concin A, Richling B, Idriceanu C, Scarpatetti M, Sedivy R, Bankl HC, Stiglbauer W, Preusser M, Rössler K, Hainfellner JA (2009) The Austrian Brain Tumour Registry: a cooperative way to establish a population-based brain tumour registry. J Neurooncol 95:401–411. https://doi.org/10.1007/s11060-009-9938-9
Fuentes-Raspall R, Solans M, Roca-Barceló A, Vilardell L, Puigdemont M, del Barco S, Comas R, García-Velasco A, Astudillo A, Carmona-Garcia MC, Marcos-Gragera R (2017) Descriptive epidemiology of primary malignant and non-malignant central nervous tumors in Spain: results from the Girona Cancer Registry (1994–2013). Cancer Epidemiol 50:1–8. https://doi.org/10.1016/j.canep.2017.07.005
Ostrom QT, Patil N, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS (2020) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013–2017. Neuro Oncol 22:1–96. https://doi.org/10.1093/neuonc/noaa200
Walker EV, Davis FG, Shaw A, Louchini R, Shack L, Woods R, Kruchko C, Spinelli J, Guiot M-C, Perry J, Melin B, Barnholtz-Sloan J, Turner D, King M, Hannah H, Bryant H (2019) Malignant primary brain and other central nervous system tumors diagnosed in Canada from 2009 to 2013. Neuro Oncol. 21:360–369. https://doi.org/10.1093/neuonc/noy195
Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97–109. https://doi.org/10.1007/s00401-007-0243-4
Crocetti E, Trama A, Stiller C, Caldarella A, Soffietti R, Jaal J, Weber DC, Ricardi U, Slowinski J, Brandes A (2012) Epidemiology of glial and non-glial brain tumours in Europe. Eur J Cancer 48:1532–1542. https://doi.org/10.1016/j.ejca.2011.12.013
AIRTUM Working Group, Busco S, Buzzoni C, Mallone S, Trama A, Castaing M, Bella F, Amodio R, Bizzoco S, Cassetti T, Cirilli C, Cusimano R, de Angelis R, Fusco M, Gatta G, Gennaro V, Giacomin A, Giorgi Rossi P, Mangone L, Mannino S, Rossi S, Pierannunzio D, Tavilla A, Tognazzo S, Tumino R, Vicentini M, Vitale MF, Crocetti E, Dal Maso L (2016) Italian cancer figures-Report 2015: the burden of rare cancers in Italy. Epidemiol Prev 40:1–120. https://doi.org/10.19191/EP16.1S2.P001.035
Korja M, Raj R, Seppä K, Luostarinen T, Malila N, Seppälä M, Mäenpää H, Pitkäniemi J (2019) Glioblastoma survival is improving despite increasing incidence rates: a nationwide study between 2000 and 2013 in Finland, Neuro. Oncol 21:370–379. https://doi.org/10.1093/neuonc/noy164
Ostrom QT, Fahmideh MA, Cote DJ, Muskens IS, Schraw JM, Scheurer ME, Bondy ML (2019) Risk factors for childhood and adult primary brain tumors, Neuro. Oncol 21:1357–1375. https://doi.org/10.1093/neuonc/noz123
Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, von Deimling A, Ellison DW (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 23:1231–1251. https://doi.org/10.1093/neuonc/noab106
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None.
Ethical approval
The study was approved by the local Institutional Review Board and conducted in line with the ethical rules for data collection.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Pierri, V., Dagostino, S., Vasta, R. et al. Incidence and spatial distribution of adult-onset primary malignant and other central nervous system tumors in Southern Sardinia, Italy. Neurol Sci 43, 419–425 (2022). https://doi.org/10.1007/s10072-021-05747-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-021-05747-5